Michelson Medical Research Foundation, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001965304

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q3 2026 · 21 positions · Total reported value $112.52M · Top-10 concentration 74.6% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 3 new · 0 cut · 3 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.5% · vs SPY -4.7% · Prev Value $108.22M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +1.6% · vs SPY -0.6% · Latest Value $112.52M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Michelson Medical Research Foundation, Inc. disclosed 21 equity positions with a combined reported value of $112.52M. The filing implies a focused portfolio: its ten largest positions account for 74.6% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q3 2026 were AMRZ ($14.96M), IVE ($11.85M), VEA ($11.17M). By sector, the heaviest allocations are Consumer Discretionary 13.5%, Industrials 13.3%. Versus the prior quarter, allocation shifted toward Industrials (+13.3pp), Health Care (+7.6pp) and away from Real Estate (-1.2pp), Energy (-1.4pp).

Versus the prior quarter, Michelson Medical Research Foundation, Inc. opened 3 new positions, trimmed 0 and fully exited 3, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q3 2026 were AMRZ ($14.96M), ISRG ($8.54M), MCD ($1.29M).

Of the 3 positions fully exited versus the prior quarter, the largest were BLDR ($8.68M), CME ($8.61M), CRGY ($1.53M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AMRZ AMRIZE LTD · $14.96M
  • ISRG INTUITIVE SURGICAL INC · $8.54M
  • MCD MCDONALDS CORP · $1.29M

Fully Exited (vs previous quarter)

  • BLDR BUILDERS FIRSTSOURCE INC · prev qtr: $8.68M
  • CME CME GROUP INC · prev qtr: $8.61M
  • CRGY CRESCENT ENERGY COMPANY · prev qtr: $1.53M

Insider Transactions (Form 4)

Latest Michelson Medical Research Foundation, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Michelson Medical Research Foundation, Inc. is an SEC-registered 13F filer. As of Q3 2026 it reported 21 US equity positions with a combined value of $112.52M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 21 positions · $112.52M reported value (Q3 2026)
  • Top 10 holdings = 74.6% of reported value
  • Largest position: AMRZ (AMRIZE LTD) at 13.3%
  • Average position size: $5.36M

Sector Tilt

  • Consumer Discretionary 13.5%
  • Industrials 13.3%
  • Health Care 7.6%
  • (classified holdings cover 39% of value)

Quarterly Activity

  • Q3 2026: 3 new, 3 exited
  • 18 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Neutral, with modest sector tilts; no major active bets (only 3 new positions, all small-mid caps). 2. Key moves: Added AMRZ (Industrials, 13.29%) and ISRG (Health Care, 7.59%); no reductions (action field shows no "Reduce" trades). 3. Portfolio structure: Mostly passive (ETFs dominate), slight bias to industrials/health care; low turnover (all held positions unchanged shares). 4. Per-holding one-liner: - AMRZ: AMRIZE LTD (unverified, Industrials). - IVE: iShares MSCI EAFE (developed ex-US). - VEA: Vanguard FTSE Developed Markets (ex-US, tax-managed). - ISRG: Intuitive Surgical (robotics, Health Care). - VWO: Vanguard FTSE Emerging Markets. - IBB: iShares Nasdaq Biotechnology. - CNNE: CannaE Holdings (unverified, Consumer Discretionary). - IWC: iShares Russell Micro-Cap. - KRE: SPDR S&P Regional Banking. - MANU: Manchester United PLC (Consumer Discretionary). 5. Style summary: Passive-core portfolio with minor, opportunistic additions in industrials and health care.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 13:25

Sector Allocation

Industrials 13.3%
Financials 1.8%
Other 60.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 400.00K $14.96M 13.29%
13.29%
New
2 51.91K $11.85M 10.53%
10.53%
Hold
3 158.16K $11.17M 9.93%
9.93%
Hold
4 21.00K $8.54M 7.59%
7.59%
New
5 127.63K $7.57M 6.73%
6.73%
Hold
6 35.09K $7.39M 6.57%
6.57%
Hold
7 480.60K $7.37M 6.55%
6.55%
Hold
8 35.38K $6.54M 5.81%
5.81%
Hold
9 63.51K $4.41M 3.92%
3.92%
Hold
10 200.00K $4.19M 3.72%
3.72%
Hold
11 20.16K $3.68M 3.27%
3.27%
Hold
12 297.48K $3.50M 3.11%
3.11%
Hold
13 11.01K $3.13M 2.78%
2.78%
Hold
14 27.43K $3.10M 2.75%
2.75%
Hold
15 81.30K $3.03M 2.69%
2.69%
Hold
16 41.85K $2.98M 2.64%
2.64%
Hold
17 45.13K $2.39M 2.12%
2.12%
Hold
18 170.10K $2.02M 1.80%
1.80%
Hold
19 20.10K $1.96M 1.74%
1.74%
Hold
20 16.75K $1.45M 1.29%
1.29%
Hold
21 5.60K $1.29M 1.15%
1.15%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 20% of its Top-10 each quarter and backtests at F1 78% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 78% · recall 78% · F1 78% · avg rank error 2.6 · Top-10 turnover 20%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 90% 90% 90% HYG · BKLN · BSV · VWO · IVE · IVV · AVB · HDV · VEA · KRE HYG · VEA · BKLN · BSV · VWO · IVE · IVV · AVB · HDV · IBB
2024-Q2 60% 60% 60% HYG · VEA · BKLN · BSV · VWO · IVE · IVV · AVB · HDV · IBB VEA · VWO · IVE · AVB · IVV · GDX · IBB · KRE · ARE · PLD
2024-Q3 70% 70% 70% VEA · VWO · IVE · AVB · IVV · GDX · IBB · KRE · ARE · PLD VEA · VWO · IVE · GDX · MTN · IVV · SUI · KRE · IBB · CMP
2024-Q4 90% 90% 90% VEA · VWO · IVE · GDX · MTN · IVV · SUI · KRE · IBB · CMP MTN · IVE · IVV · GDX · VEA · CMP · EL · IBB · VWO · KRE
2025-Q1 70% 70% 70% MTN · IVE · IVV · GDX · CMP · VEA · EL · IBB · VWO · IWC MTN · IJS · RTO · GDX · IVE · IVV · VEA · VWO · IBB · KRE
2025-Q2 70% 70% 70% MTN · RTO · IJS · GDX · IVE · IVV · VEA · IBB · VWO · KRE MTN · GDX · RTO · IVE · VEA · VWO · DBRG · SAFE · IWC · IBB
2025-Q3 90% 90% 90% MTN · RTO · GDX · IVE · VEA · VWO · DBRG · SAFE · IWC · IBB GDX · MTN · SGOV · IVE · VEA · DBRG · VWO · IWC · IBB · SAFE
2025-Q4 80% 80% 80% GDX · MTN · SGOV · IVE · VEA · DBRG · VWO · IWC · IBB · SAFE MTN · IVE · UNH · VEA · DBRG · VWO · IBB · IWC · KRE · SAFE
2026-Q1 90% 90% 90% MTN · IVE · VEA · UNH · DBRG · VWO · IBB · IWC · KRE · SAFE MTN · IVE · VEA · UNH · VWO · IBB · IWC · CNNE · KRE · SAFE
2026-Q2 80% 80% 80% MTN · IVE · VEA · UNH · VWO · IBB · IWC · CNNE · KRE · SAFE IVE · VEA · BLDR · CME · VWO · IWC · CNNE · IBB · KRE · SAFE
2026-Q3 ★ 70% 70% 70% IVE · VEA · BLDR · CME · VWO · IWC · CNNE · IBB · KRE · SAFE AMRZ · IVE · VEA · ISRG · VWO · IBB · CNNE · IWC · KRE · MANU

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings6 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-3.26%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+13.75%vs benchmark
Barra annualised vol26.9%Model estimate
Realised vol23.8%Annualised in window
Weighted beta1.05Raw exposure
Factor / specific risk75% / 25%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16Michelson Medical Research Foundation, Inc.QQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-3.26%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+13.75%Portfolio − benchmark
Arithmetic return sum-2.95%Difference vs compounded is the cross term
Weighted raw beta1.05Weighted holding betas
Realised volatility (annualised)23.78%Daily returns in window
Barra model volatility (annualised)26.86%Factor + specific
Factor share of variance74.9%Barra factors
Specific share of variance25.1%Stock residuals
Reported value$30.1M13F long US equity

2. Return attribution

The -2.95% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -2.50% -84.5%
Momentum & Growth 3 -0.85% -28.8%
Volatility & Tail Risk 7 +1.57% 53.3%
Industry 12 +8.02% 271.6%
Specific 1 -9.20% -311.6%
Return attribution (style + industry, %)-5.7-2.8+0.0+2.8+5.7Short-term Reversal-0.46Mid Cap-0.48Max Drawdown-0.50Non-linear Size-0.51Size-0.53Leverage (Downside Vol)-0.77Consumer Discretionary+0.82Beta+0.83Turnover-1.03Skewness+1.70Health Care+1.98Residual Volatility-4.55Other+5.22Historical Volatility+5.26
Factor Type Exposure Factor return Contribution Share of |return|
Historical Volatility Style -0.38 -14.00% +5.26% 178.0%
Other Industry +0.59 +8.78% +5.22% 176.7%
Health Care Industry +0.28 +6.98% +1.98% 67.1%
Skewness Style -0.39 -4.39% +1.70% 57.4%
Beta Style +0.19 +4.44% +0.83% 28.3%
Consumer Discretionary Industry +0.12 +6.71% +0.82% 27.8%
Amihud Illiquidity Style -0.56 -0.45% +0.25% 8.5%
Liquidity Style -0.55 +0.36% -0.20% -6.7%
Momentum Style +0.09 -4.00% -0.37% -12.5%
Kurtosis Style -0.05 +7.51% -0.39% -13.1%
Short-term Reversal Style -0.53 +0.87% -0.46% -15.6%
Mid Cap Style +0.25 -1.94% -0.48% -16.2%
Max Drawdown Style +0.28 -1.76% -0.50% -16.8%
Non-linear Size Style -0.51 +1.01% -0.51% -17.4%
Size Style +0.27 -1.95% -0.53% -18.0%
Leverage (Downside Vol) Style +0.45 -1.71% -0.77% -26.2%
Turnover Style +0.21 -4.80% -1.03% -34.8%
Residual Volatility Style -1.38 +3.29% -4.55% -154.2%
Specific Specific — — -9.20% -311.6%

3. Risk attribution

Annualised volatility is 26.86%; factor risk explains 74.9% of variance and specific risk 25.1%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-44.4-22.2+0.0+22.2+44.4Max Drawdown-2.22Size-1.71Skewness-1.37Historical Volatility+0.89Mid Cap+1.02Amihud Illiquidity+1.53Short-term Reversal+1.63Liquidity+1.92Beta+2.02Consumer Discretionary+3.38Health Care+9.76Residual Volatility+15.13Specific+25.09Other+41.14
Factor Type Exposure Share of variance Vol contribution Share of vol
Other Industry +0.59 41.1% +11.05% 11.1%
Specific Specific — 25.1% +6.74% 6.7%
Residual Volatility Style -1.38 15.1% +4.06% 4.1%
Health Care Industry +0.28 9.8% +2.62% 2.6%
Consumer Discretionary Industry +0.12 3.4% +0.91% 0.9%
Beta Style +0.19 2.0% +0.54% 0.5%
Liquidity Style -0.55 1.9% +0.52% 0.5%
Short-term Reversal Style -0.53 1.6% +0.44% 0.4%
Amihud Illiquidity Style -0.56 1.5% +0.41% 0.4%
Mid Cap Style +0.25 1.0% +0.27% 0.3%
Historical Volatility Style -0.38 0.9% +0.24% 0.2%
Non-linear Size Style -0.51 0.7% +0.18% 0.2%
Turnover Style +0.21 0.5% +0.14% 0.1%
Momentum Style +0.09 0.4% +0.10% 0.1%
Skewness Style -0.39 -1.4% -0.37% -0.4%
Size Style +0.27 -1.7% -0.46% -0.5%
Max Drawdown Style +0.28 -2.2% -0.60% -0.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.7-0.70.41.42.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size +0.27 +2.10 -1.83
Non-linear Size -0.51 +1.68 -2.19
Mid Cap +0.25 +0.13 +0.12
Beta +0.19 +1.29 -1.11
Momentum +0.09 +0.72 -0.62
Short-term Reversal -0.53 -0.64 +0.11
Residual Volatility -1.38 -0.40 -0.98
Historical Volatility -0.38 +0.86 -1.24
Liquidity -0.55 +0.11 -0.67
Amihud Illiquidity -0.56 +1.16 -1.72
Turnover +0.21 +0.21 +0.01
Growth -0.01 +0.58 -0.60
Leverage (Downside Vol) +0.45 +0.14 +0.31
Skewness -0.39 +0.24 -0.62
Kurtosis -0.05 +0.21 -0.27
Max Drawdown +0.28 -0.08 +0.36

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesIndustrialsConsumer DiscretionaryHealth CareOtherPortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Health Care 28.4% 1.7% +7.65% +8.29% +6.77% -0.01% -0.17% +2.03%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Consumer Discretionary 12.2% 8.8% +4.46% +3.76% +0.71% +0.06% +0.02% +0.21%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Other 59.4% 0.0% -10.20% +0.00% +10.18% -0.00% -6.06% -6.06%
Total +18.51% +16.22% -22.38% +12.35%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
VEA VANGUARD TAX-MANAGED FDS Other 37.10% -3.38% -1.26% Hold
ISRG INTUITIVE SURGICAL INC Health Care 28.37% +7.65% +2.17% New
EWY ISHARES INC Other 12.24% -25.29% -3.09% Hold
EWZ ISHARES INC Other 10.06% -16.99% -1.71% Hold
BATRK ATLANTA BRAVES HLDGS INC Consumer Discretionary 7.94% -3.38% -0.27% Hold
MCD MCDONALDS CORP Consumer Discretionary 4.30% +18.94% +0.81% New
Contribution rank Symbol Sector Weight Return Contribution
1 ISRG Health Care 28.37% +7.65% +2.17%
2 MCD Consumer Discretionary 4.30% +18.94% +0.81%
3 BATRK Consumer Discretionary 7.94% -3.38% -0.27%
4 VEA Other 37.10% -3.38% -1.26%
5 EWZ Other 10.06% -16.99% -1.71%
6 EWY Other 12.24% -25.29% -3.09%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -3.26%, versus -17.01% for the QQQ synthetic benchmark — an excess of +13.75%.
  2. Return attribution: the largest positive style/industry contributions came from Historical Volatility +5.26%, Other +5.22%, Health Care +1.98%; the largest drags came from Residual Volatility -4.55%, Turnover -1.03%, Leverage (Downside Vol) -0.77%. Specific (stock-level) return contributed -9.20%.
  3. Risk attribution: Barra model volatility is 26.86% annualised; factor risk explains 75% of variance and specific risk 25%. The largest factor risk sources are Other 41.1%, Residual Volatility 15.1%, Health Care 9.8%.
  4. Style tilt: size +0.27, momentum +0.09, volatility -0.38, liquidity -0.55; the weighted raw beta is 1.05. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Other (+59.4 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +18.51%, selection +16.22% and interaction -22.38%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Michelson Medical Research Foundation, Inc. buy in 2026-Q3?

In its 2026-Q3 13F filing, Michelson Medical Research Foundation, Inc. reported 21 equity positions worth $112.52M in aggregate; its largest disclosed positions were AMRZ ($14.96M), IVE ($11.85M), VEA ($11.17M).

How large is Michelson Medical Research Foundation, Inc.'s portfolio?

Michelson Medical Research Foundation, Inc. reported $112.52M of long equity holdings across 21 positions as of 2026-Q3. Top-10 holdings account for 74.6% of reported value.

What is Michelson Medical Research Foundation, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/michelson-medical-research-foundation/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →